Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $29.5 Million - $34.2 Million
-97,148 Reduced 57.17%
72,770 $25.2 Million
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $45.5 Million - $61.7 Million
168,970 Added 17823.84%
169,918 $54.9 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $332,037 - $400,653
948 New
948 $339,000
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $2.61 Million - $3.38 Million
-7,407 Reduced 46.47%
8,532 $3.59 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $2.09 Million - $2.85 Million
5,058 Added 46.48%
15,939 $6.65 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $8.18 Million - $10.5 Million
-17,640 Reduced 61.85%
10,881 $5.39 Million
Q1 2022

May 09, 2022

SELL
$524.57 - $735.42 $673,023 - $943,543
-1,283 Reduced 4.3%
28,521 $16.1 Million
Q4 2021

Feb 01, 2022

BUY
$708.84 - $794.68 $4.39 Million - $4.92 Million
6,194 Added 26.23%
29,804 $22.5 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $15.2 Million - $19.1 Million
23,121 Added 4728.22%
23,610 $17.6 Million
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $6.29 Million - $7.08 Million
-10,915 Reduced 95.71%
489 $315,000
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $6.24 Million - $7.55 Million
11,404 New
11,404 $6.51 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $4.89 Million - $6.17 Million
-9,585 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $8.39 Million - $9.89 Million
-18,473 Reduced 65.84%
9,585 $4.94 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $9.19 Million - $13.5 Million
27,445 Added 4477.16%
28,058 $12.7 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $11,200 - $14,317
35 Added 6.06%
613 $215,000
Q4 2019

Feb 13, 2020

BUY
$319.73 - $374.2 $184,803 - $216,287
578 New
578 $214,000
Q3 2019

Nov 13, 2019

SELL
$304.55 - $345.24 $224,757 - $254,787
-738 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$286.93 - $312.59 $211,754 - $230,691
738 New
738 $231,000
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $167,936 - $235,767
-763 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $180,510 - $203,517
624 Added 448.92%
763 $239,000
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $33,929 - $42,239
139 New
139 $40,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.